Mutations leading to activation of the protein tyrosine phosphatase SHP2 (encoded by the PTPN11 gene) are linked to a specific MPN form, juvenile myelomonocytic leukemia. The gene discussed is PTPN11; the disease is myeloproliferative neoplasm.